BBIO - BridgeBio submits FDA market application for ATTR-CM drug
2023-12-05 12:04:02 ET
More on BridgeBio Pharma
- BridgeBio Pharma: Taking Some Profits
- BridgeBio: Bets Acoramidis As The Pfizer Spoiler
- BridgeBio draws Buy rating at Cantor citing 100% upside
- BridgeBio Pharma to issue 9.2M shares through PIPE financing
- Seeking Alpha’s Quant Rating on BridgeBio Pharma
For further details see:
BridgeBio submits FDA market application for ATTR-CM drug